Bioo Scientific Awarded $550K to Improve Single Cell Sequencing Technologies
News Apr 11, 2016
Bioo Scientific is developing tools which will allow researchers to study dynamic variation in epigenomics from a single cell. Until now, single-cell analysis of DNA methylation has proven itself to be technically challenging and there are no kits commercially available which can facilitate this analysis. Bioo Scientific was recently awarded two Small Business Innovation Research (SBIR) grants from the National Institutes of Health (NIH) to develop innovative solutions to improve single cell sequencing.
The first grant, Sequencing of Epigenetic Modifications from Single Cells, will be used to further the development of single-cell methylome sequencing for use in in a number of applications, including epigenome analysis of heterogeneous organs and research on epigenetic drug resistance.
The second grant, DGE Analysis by 3’ End Sequencing, will allow researchers to sequence the 3’ end of RNA molecules. Existing 3’ end sequencing protocols have revealed that most eukaryotic genes display alternative cleavage and polyadenylation (APA), where RNA isoforms using different cleavage and polyadenylation sites (pAs) can be generated from the same gene. Importantly, these different isoforms have been shown to be metabolized differently, including variations in stability, localization, and translation. With this grant, Bioo Scientific will develop a new tool that completely addresses false priming and incomplete 3' end annotation, significantly advancing research on single cell RNA expression.
The kits Bioo Scientific will develop with this funding have the potential to have a positive impact on both basic research and clinical analysis in the future.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.
Ancient Syphilis Genomes Decoded for First TimeNews
Researchers recovered three genomes of the bacterium Treponema pallidum from skeletal remains from colonial-era Mexico, and were able to distinguish the subspecies that causes syphilis from the subspecies that causes yaws. It was not previously thought possible to recover DNA from this bacterium from ancient samples.